查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1454802

靜脈注射藥物設備市場：依產品類型、最終用戶、地區：全球產業分析、規模、佔有率、成長、趨勢、預測 2023-2030

IV Fluid Transfer Drug Devices Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030
出版日期: | 出版商: Persistence Market Research | 英文 197 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research 發佈了一份關於全球靜脈注射藥物設備市場的富有洞察力的報告。這種全面的分析提供了對關鍵市場動態、市場驅動因素、課題和新興趨勢的寶貴見解。該報告詳細概述了靜脈注射藥物器材產業，並提供了獨家數據和統計數據，以預測 2023 年至 2030 年的市場成長軌跡。

全球靜脈輸液藥物器材市場預計將以 3.5% 的複合年增長率成長，從 2023 年的 67 億美元成長到 2030 年底的 85 億美元。

重要見解

  • 靜脈輸注藥物裝置市場規模（2023年）：67億美元
  • 預計市值（2030 年）：85 億美元
  • 全球市場成長率（2023-2030年複合年增長率）：3.5%
  • 過去的市場成長率（2018-2022年複合年增長率）：2.3%

靜脈注射藥物器材市場：研究範圍

由於慢性病的增加、對家庭醫療保健解決方案的需求不斷增長以及藥物輸送技術的進步，靜脈輸注藥物設備市場預計將顯著增長。該市場為醫療機構、家庭護理機構和製藥製造商提供各種專為安全、高效的給藥而設計的靜脈輸注藥物設備。人口老化、慢性病的增加以及遠距醫療和遠距患者監護服務的擴展正在推動市場成長。

市場驅動因素：

全球靜脈注射藥物設備市場受益於幾個關鍵的市場驅動因素。癌症、糖尿病和心血管疾病等慢性疾病的盛行率不斷上升、人口老化以及醫療保健支出的增加正在推動市場擴張。輸液設備提供了給藥的便利性、靈活性和準確性，提高了患者的依從性和治療結果。此外，輸液幫浦技術、智慧輸液系統和穿戴式藥物傳輸設備的進步使得個人化和連續的治療監測成為可能。此外，家庭輸液服務的擴張、特種藥物的興起以及基於價值的醫療保健模式的採用也正在影響市場。

市場限制因素：

儘管成長前景廣闊，靜脈注射藥物器材市場仍面臨監管合規、報銷政策和病人安全等方面的課題。管理醫療器材設計、製造和銷售的嚴格法規給製造商和醫療保健提供者帶來了合規負擔。此外，家庭輸液治療和特殊藥物的報銷有限可能會阻礙市場滲透。此外，對用藥錯誤、藥物交互作用和輸液幫浦故障的擔憂會影響病人安全和輸液設備的可靠性。解決這些障礙需要行業利益相關者、監管機構和醫療保健支付者共同努力，確保患者獲得安全有效的藥物輸送解決方案。

市場機會：

由於技術創新、人口趨勢和不斷發展的醫療保健服務模式，靜脈注射藥物設備市場呈現巨大的成長機會。無線連接、遠端監控和智慧感測器等數位健康技術的整合將改善患者接受靜脈治療的機會，並提高治療依從性和結果。此外，家庭輸液服務、門診輸液中心和專業藥房網路的擴張擴大了市場範圍並刺激了創新。戰略合作夥伴關係、研發投資以及推出易於使用、具有成本效益的藥物輸送設備對於利用新的商機並保持在動態靜脈治療市場的領先地位至關重要。

本報告解決的關鍵問題

  • 全球靜脈輸注藥物設備市場的預期複合年增長率是多少？
  • 2023年市場規模有多大？
  • 2023年哪個國家將佔據最大的市場佔有率？
  • 誰是全球靜脈輸液藥物器材市場的主要參與者？
  • 依應用劃分，哪些市場成長最快？

目錄

第一章執行摘要

第二章市場概況

  • 市場範圍和定義
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
    • 任務
    • 主要趨勢
  • 應用程式生命週期分析
  • 靜脈注射藥物器材市場：價值鏈
    • 原材料供應商名單
    • 製造商名單
    • 經銷商名單
    • 應用清單
    • 獲利能力分析
  • 波特五力分析
  • 地緣政治緊張局勢：對市場的影響
  • 宏觀經濟因素
    • 世界產業展望
    • 世界GDP成長率展望
    • 全球母公司市場概覽
  • 預測變量 - 相關性和影響
  • 監管和技術格局

第三章全球靜脈注射藥物器材市場展望：實際（2018-2022）與預測（2023-2030）

  • 主要亮點
    • 市場容量（單位）預測
    • 市場規模及年成長率
    • 絕對的獲利機會
  • 市場規模（百萬美元）分析與預測
    • 過去的市場規模分析，2013-2016
    • 目前市場規模預測，2018-2026
  • 全球靜脈注射藥物器材市場展望：應用
    • 簡介/主要發現
    • 2018-2022 年依應用劃分的過去市場規模（百萬美元）和數量（單位）分析
    • 2023-2030 年當前市場規模（百萬美元）和依應用劃分的數量（單位）預測
      • 自身免疫性疾病
      • 血液病
      • 心血管疾病
      • 神經病學
      • 腫瘤學
      • 其他
  • 市場吸引力分析：應用
  • 全球靜脈注射藥物設備市場展望：最終用戶
    • 簡介/主要發現
    • 2018-2022 年最終用戶過去的市場規模（百萬美元）和數量（單位）分析
    • 當前市場規模（百萬美元）和最終用戶預測數量（單位），2023-2030 年
      • 醫院
      • 專科診所
      • 其他
  • 市場吸引力分析：最終用戶

第四章全球靜脈注射藥物器材市場展望：地區

  • 主要亮點
  • 2018-2022 年依地區歷史市場規模（百萬美元）及成交量（單位）分析
  • 2023-2030 年依地區劃分的當前市場規模（百萬美元）和預測數量（單位）
    • 北美
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東和非洲 (MEA)
  • 市場吸引力分析：區域

第五章北美 IV 輸注藥物器材市場展望：實際（2018-2022）與預測（2023-2030）

  • 主要亮點
  • 價格分析
  • 2018-2022 年依市場劃分的過往市場規模（百萬美元）和銷售量（單位）分析
    • 依國家
    • 依用途
    • 依最終用戶
  • 2023-2030 年各國目前市場規模（百萬美元）及銷售量（單位）預測
    • 美國
    • 加拿大
  • 2023-2030 年當前市場規模（百萬美元）和依應用劃分的數量（單位）預測
    • 自身免疫性疾病
    • 血液病
    • 心血管疾病
    • 神經病學
    • 腫瘤學
    • 其他
  • 當前市場規模（百萬美元）和最終用戶預測數量（單位），2023-2030 年
    • 醫院
    • 專科診所
    • 其他
  • 市場吸引力分析

第六章歐洲IV輸注藥物器材市場展望：實際（2018-2022）與預測（2023-2030）

  • 主要亮點
  • 價格分析
  • 2018-2022 年依市場劃分的過往市場規模（百萬美元）和銷售量（單位）分析
    • 依國家
    • 依用途
    • 依最終用戶
  • 2023-2030 年各國目前市場規模（百萬美元）及銷售量（單位）預測
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 土耳其
    • 歐洲其他地區
  • 2023-2030 年當前市場規模（百萬美元）和依應用劃分的數量（單位）預測
    • 自身免疫性疾病
    • 血液病
    • 心血管疾病
    • 神經病學
    • 腫瘤學
    • 其他
  • 當前市場規模（百萬美元）和最終用戶預測數量（單位），2023-2030 年
    • 醫院
    • 專科診所
    • 其他
  • 市場吸引力分析

第七章東亞IV輸注藥物器材市場展望：實際（2018-2022）與預測（2023-2030）

  • 主要亮點
  • 價格分析
  • 2018-2022 年依市場劃分的過往市場規模（百萬美元）和銷售量（單位）分析
    • 依國家
    • 依用途
    • 依最終用戶
  • 2023-2030 年各國目前市場規模（百萬美元）及銷售量（單位）預測
    • 中國
    • 日本
    • 韓國
  • 2023-2030 年當前市場規模（百萬美元）和依應用劃分的數量（單位）預測
    • 自身免疫性疾病
    • 血液病
    • 心血管疾病
    • 神經病學
    • 腫瘤學
    • 其他
  • 當前市場規模（百萬美元）和最終用戶預測數量（單位），2023-2030 年
    • 醫院
    • 專科診所
    • 其他
  • 市場吸引力分析

第八章南亞和大洋洲 IV 輸注藥物器械市場展望：實際（2018-2022）和預測（2023-2030）

  • 主要亮點
  • 價格分析
  • 2018-2022 年依市場劃分的過往市場規模（百萬美元）和銷售量（單位）分析
    • 依國家
    • 依用途
    • 依最終用戶
  • 2023-2030 年各國目前市場規模（百萬美元）及銷售量（單位）預測
    • 印度
    • 東南亞
    • 紐西蘭
    • 南亞和大洋洲其他地區
  • 2023-2030 年當前市場規模（百萬美元）和依應用劃分的數量（單位）預測
    • 自身免疫性疾病
    • 血液病
    • 心血管疾病
    • 神經病學
    • 腫瘤學
    • 其他
  • 當前市場規模（百萬美元）和最終用戶預測數量（單位），2023-2030 年
    • 醫院
    • 專科診所
    • 其他
  • 市場吸引力分析

第9章拉丁美洲IV輸注藥物器械市場展望：實際（2018-2022）與預測（2023-2030）

  • 主要亮點
  • 價格分析
  • 2018-2022 年依市場劃分的過往市場規模（百萬美元）和銷售量（單位）分析
    • 依國家
    • 依用途
    • 依最終用戶
  • 2023-2030 年各國目前市場規模（百萬美元）及銷售量（單位）預測
    • 巴西
    • 墨西哥
    • 其他拉丁美洲
  • 2023-2030 年當前市場規模（百萬美元）和依應用劃分的數量（單位）預測
    • 自身免疫性疾病
    • 血液病
    • 心血管疾病
    • 神經病學
    • 腫瘤學
    • 其他
  • 當前市場規模（百萬美元）和最終用戶預測數量（單位），2023-2030 年
    • 醫院
    • 專科診所
    • 其他
  • 市場吸引力分析

第10章中東和非洲IV輸注藥物器械市場展望：實際（2018-2022）和預測（2023-2030）

  • 主要亮點
  • 價格分析
  • 2018-2022 年過去的市場規模（百萬美元）與市場銷售（單位）分析
    • 依國家
    • 依用途
    • 依最終用戶
  • 2023-2030 年各國目前市場規模（百萬美元）及銷售量（單位）預測
    • 海灣合作委員會
    • 埃及
    • 南非
    • 北非
    • 其他中東和非洲
  • 2023-2030 年當前市場規模（百萬美元）和依應用劃分的數量（單位）預測
    • 自身免疫性疾病
    • 血液病
    • 心血管疾病
    • 神經病學
    • 腫瘤學
    • 其他
  • 當前市場規模（百萬美元）和最終用戶預測數量（單位），2023-2030 年
    • 醫院
    • 專科診所
    • 其他
  • 市場吸引力分析

第十一章競爭格局

  • 2022 年市場佔有率分析
  • 市場結構
    • 依市場劃分的競爭強度圖
    • 比賽儀表板
    • 表觀應用能力
  • 公司簡介（詳細資訊 - 概述、財務、策略、近期發展）
    • Advance Medical Designs Inc.
    • B. Braun Medical
    • Baxter Healthcare
    • ICU Medical Inc.
    • Hospira
    • QI Medical Inc.
    • Pfizer
    • Unilife Corporation
    • Amedra Pharmaceuticals
    • Sanofi
    • Biogen Idec
    • BIONIK Laboratories Corp.
    • Ekso Bionics Holdings Inc.

第十二章附錄

  • 調查方法
  • 調查假設
  • 縮寫
簡介目錄
Product Code: PMRREP33966

Persistence Market Research, a renowned market research firm, has recently released an insightful report on the global IV Fluid Transfer Drug Devices Market. This comprehensive analysis offers valuable insights into key market dynamics, growth drivers, challenges, and emerging trends. The report provides a detailed overview of the IV fluid transfer drug devices industry, featuring exclusive data and statistics projecting the market's growth trajectory from 2023 to 2030.

The global IV fluid transfer drug devices market is forecast to expand at a CAGR of 3.5% and thereby increase from a value of US$6.7 Bn in 2023, to US$8.5 Bn by the end of 2030.

Key Insights:

  • IV Fluid Transfer Drug Devices Market Size (2023): US$6.7 Bn
  • Projected Market Value (2030): US$8.5 Bn
  • Global Market Growth Rate (CAGR 2023 to 2030): 3.5%
  • Historical Market Growth Rate (CAGR 2018 to 2022): 2.3%

IV Fluid Transfer Drug Devices Market - Report Scope:

The IV Fluid Transfer Drug Devices Market is poised for significant growth, driven by the increasing prevalence of chronic diseases, the rising demand for home healthcare solutions, and advancements in drug delivery technologies. This market serves healthcare institutions, homecare settings, and pharmaceutical manufacturers, offering a range of IV fluid transfer devices designed for safe and efficient drug administration. Market growth is fueled by the aging population, the growing incidence of chronic conditions, and the expansion of telemedicine and remote patient monitoring services.

Market Growth Drivers:

The global IV Fluid Transfer Drug Devices Market benefits from several key growth drivers. The growing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders, coupled with the aging population and increasing healthcare expenditure, drives market expansion. IV fluid transfer devices offer convenience, flexibility, and accuracy in drug administration, enhancing patient compliance and treatment outcomes. Moreover, advancements in infusion pump technologies, smart infusion systems, and wearable drug delivery devices enable personalized and continuous therapy monitoring. The market is also influenced by the expansion of home infusion services, the rise of specialty pharmaceuticals, and the adoption of value-based healthcare models.

Market Restraints:

Despite promising growth prospects, the IV Fluid Transfer Drug Devices Market faces challenges related to regulatory compliance, reimbursement policies, and patient safety concerns. Stringent regulations governing the design, manufacturing, and marketing of medical devices impose compliance burdens on manufacturers and healthcare providers. Additionally, reimbursement limitations for home infusion therapy and specialty drugs may hinder market penetration. Furthermore, concerns related to medication errors, drug interactions, and infusion pump malfunctions impact patient safety and trust in IV fluid transfer devices. Addressing these barriers requires collaboration between industry stakeholders, regulatory authorities, and healthcare payers to ensure patient access to safe and effective drug delivery solutions.

Market Opportunities:

The IV Fluid Transfer Drug Devices Market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The integration of digital health technologies, such as wireless connectivity, remote monitoring, and smart sensors, enhances patient access to IV therapy and improves treatment adherence and outcomes. Furthermore, the expansion of home infusion services, ambulatory infusion centers, and specialty pharmacy networks broadens the market scope and stimulates innovation. Strategic partnerships, investment in research and development, and the introduction of user-friendly, cost-effective drug delivery devices are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic landscape of IV therapy.

Key Questions Answered in the Report:

  • What is the Forecast CAGR of the Global IV Fluid Transfer Drug Devices Market?
  • What was the Market Size in the Year 2023?
  • Which Country Held the Largest Market Share in 2023?
  • Who are the Key Players in the Global IV Fluid Transfer Drug Devices Market?
  • Which is the Fastest-growing Segment of the Market by Application?

Competitive Intelligence and Business Strategy:

Leading players in the global IV Fluid Transfer Drug Devices Market, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in the development of advanced infusion pumps, drug delivery systems, and infusion sets, exploring novel materials and wireless connectivity options to enhance device functionality and user experience. Collaborations with healthcare providers, home infusion companies, and specialty pharmacies facilitate market access and improve the adoption of IV fluid transfer devices. Moreover, emphasis on patient education, training programs, and 24/7 technical support services fosters market growth and enhances patient safety in the rapidly evolving landscape of home infusion therapy and specialty drug administration.

Key Companies Profiled:

  • Advance Medical Designs Inc.
  • B. Braun Medical
  • Baxter Healthcare
  • ICU Medical Inc.
  • Hospira
  • Q.I. Medical Inc.
  • Pfizer
  • Unilife Corporation
  • Amedra Pharmaceuticals
  • Sanofi
  • Biogen Idec
  • BIONIK Laboratories Corp.
  • Ekso Bionics Holdings Inc.

IV Fluid Transfer Drug Devices Market Research Segmentation:

Oncology stands out as the leading application driving global market growth in IV fluid transfer drug devices. The significant increase in the oncology category is attributed to the rising incidence of cancer and the growing use of intravenous chemotherapy treatments, where IV fluid transfer devices play a crucial role in delivering accurate dosages.

The fastest-growing market segment is neurology, fueled by the increasing prevalence of neurological illnesses worldwide. The demand for intravenous therapies in neurology, including drug administration for conditions such as neuropathic pain and multiple sclerosis, drives the rapid rise of this market sector.

Hospitals dominate the end-user segment due to their large patient volumes, diverse medical needs, and the essential role IV treatments play in acute and critical care settings. Specialist clinics represent the fastest-growing market category, driven by the rise in outpatient care and the demand for focused and customized treatments.

North America maintains dominance in the IV fluid transfer drug devices market, driven by its advanced healthcare technologies, substantial healthcare expenditure, and strong regulatory framework. The region's proactive adoption of cutting-edge healthcare technologies and the increasing prevalence of chronic diseases contribute to the high demand for IV fluid transfer devices. In contrast, the IV fluid transfer drug devices market is expanding rapidly in East Asia, propelled by rapid economic development, rising healthcare awareness, and a growing demand for advanced medical treatments in countries like China, Japan, and South Korea.

By Application:

  • Autoimmune Diseases
  • Blood Disorders
  • Cardiovascular Disorders
  • Neurology
  • Oncology
  • Others

By End User:

  • Hospitals
  • Specialized Clinics
  • Others

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global IV Fluid Transfer Drug Devices Market Snapshot, 2023 and 2030
  • 1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Application Lifecycle Analysis
  • 2.4. IV Fluid Transfer Drug Devices Market: Value Chain
    • 2.4.1. List of Raw Material Supplier
    • 2.4.2. List of Manufacturers
    • 2.4.3. List of Distributors
    • 2.4.4. List of Applications
    • 2.4.5. Profitability Analysis
  • 2.5. Porter Five Force's Analysis
  • 2.6. Geopolitical Tensions: Market Impact
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview
  • 2.8. Forecast Factors - Relevance and Impact
  • 2.9. Regulatory and Technology Landscape

3. Global IV Fluid Transfer Drug Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 3.1. Key Highlights
    • 3.1.1. Market Volume (Units) Projections
    • 3.1.2. Market Size and Y-o-Y Growth
    • 3.1.3. Absolute $ Opportunity
  • 3.2. Market Size (US$ Mn) Analysis and Forecast
    • 3.2.1. Historical Market Size Analysis, 2013-2016
    • 3.2.2. Current Market Size Forecast, 2018-2026
  • 3.3. Global IV Fluid Transfer Drug Devices Market Outlook: Application
    • 3.3.1. Introduction / Key Findings
    • 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Application, 2018 - 2022
    • 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
      • 3.3.3.1. Autoimmune Diseases
      • 3.3.3.2. Blood Disorders
      • 3.3.3.3. Cardiovascular Disorders
      • 3.3.3.4. Neurology
      • 3.3.3.5. Oncology
      • 3.3.3.6. Others
  • 3.4. Market Attractiveness Analysis: Application
  • 3.5. Global IV Fluid Transfer Drug Devices Market Outlook: End User
    • 3.5.1. Introduction / Key Findings
    • 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
    • 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
      • 3.5.3.1. Hospitals
      • 3.5.3.2. Specialized Clinics
      • 3.5.3.3. Others
  • 3.6. Market Attractiveness Analysis: End User

4. Global IV Fluid Transfer Drug Devices Market Outlook: Region

  • 4.1. Key Highlights
  • 4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
  • 4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. East Asia
    • 4.3.4. South Asia and Oceania
    • 4.3.5. Latin America
    • 4.3.6. Middle East & Africa (MEA)
  • 4.4. Market Attractiveness Analysis: Region

5. North America IV Fluid Transfer Drug Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 5.1. Key Highlights
  • 5.2. Pricing Analysis
  • 5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 5.3.1. By Country
    • 5.3.2. By Application
    • 5.3.3. By End User
  • 5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 5.4.1. U.S.
    • 5.4.2. Canada
  • 5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 5.5.1. Autoimmune Diseases
    • 5.5.2. Blood Disorders
    • 5.5.3. Cardiovascular Disorders
    • 5.5.4. Neurology
    • 5.5.5. Oncology
    • 5.5.6. Others
  • 5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 5.6.1. Hospitals
    • 5.6.2. Specialized Clinics
    • 5.6.3. Others
  • 5.7. Market Attractiveness Analysis

6. Europe IV Fluid Transfer Drug Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 6.3.1. By Country
    • 6.3.2. By Application
    • 6.3.3. By End User
  • 6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. U.K.
    • 6.4.4. Italy
    • 6.4.5. Spain
    • 6.4.6. Russia
    • 6.4.7. Turkiye
    • 6.4.8. Rest of Europe
  • 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 6.5.1. Autoimmune Diseases
    • 6.5.2. Blood Disorders
    • 6.5.3. Cardiovascular Disorders
    • 6.5.4. Neurology
    • 6.5.5. Oncology
    • 6.5.6. Others
  • 6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 6.6.1. Hospitals
    • 6.6.2. Specialized Clinics
    • 6.6.3. Others
  • 6.7. Market Attractiveness Analysis

7. East Asia IV Fluid Transfer Drug Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 7.3.1. By Country
    • 7.3.2. By Application
    • 7.3.3. By End User
  • 7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. South Korea
  • 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 7.5.1. Autoimmune Diseases
    • 7.5.2. Blood Disorders
    • 7.5.3. Cardiovascular Disorders
    • 7.5.4. Neurology
    • 7.5.5. Oncology
    • 7.5.6. Others
  • 7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 7.6.1. Hospitals
    • 7.6.2. Specialized Clinics
    • 7.6.3. Others
  • 7.7. Market Attractiveness Analysis

8. South Asia & Oceania IV Fluid Transfer Drug Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 8.3.1. By Country
    • 8.3.2. By Application
    • 8.3.3. By End User
  • 8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 8.4.1. India
    • 8.4.2. Southeast Asia
    • 8.4.3. ANZ
    • 8.4.4. Rest of South Asia & Oceania
  • 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 8.5.1. Autoimmune Diseases
    • 8.5.2. Blood Disorders
    • 8.5.3. Cardiovascular Disorders
    • 8.5.4. Neurology
    • 8.5.5. Oncology
    • 8.5.6. Others
  • 8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 8.6.1. Hospitals
    • 8.6.2. Specialized Clinics
    • 8.6.3. Others
  • 8.7. Market Attractiveness Analysis

9. Latin America IV Fluid Transfer Drug Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 9.3.1. By Country
    • 9.3.2. By Application
    • 9.3.3. By End User
  • 9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 9.5.1. Autoimmune Diseases
    • 9.5.2. Blood Disorders
    • 9.5.3. Cardiovascular Disorders
    • 9.5.4. Neurology
    • 9.5.5. Oncology
    • 9.5.6. Others
  • 9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 9.6.1. Hospitals
    • 9.6.2. Specialized Clinics
    • 9.6.3. Others
  • 9.7. Market Attractiveness Analysis

10. Middle East & Africa IV Fluid Transfer Drug Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 10.3.1. By Country
    • 10.3.2. By Application
    • 10.3.3. By End User
  • 10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 10.4.1. GCC
    • 10.4.2. Egypt
    • 10.4.3. South Africa
    • 10.4.4. Northern Africa
    • 10.4.5. Rest of Middle East & Africa
  • 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 10.5.1. Autoimmune Diseases
    • 10.5.2. Blood Disorders
    • 10.5.3. Cardiovascular Disorders
    • 10.5.4. Neurology
    • 10.5.5. Oncology
    • 10.5.6. Others
  • 10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 10.6.1. Hospitals
    • 10.6.2. Specialized Clinics
    • 10.6.3. Others
  • 10.7. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2022
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping By Market
    • 11.2.2. Competition Dashboard
    • 11.2.3. Apparent Application Capacity
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. Advance Medical Designs Inc.
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Application
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. B. Braun Medical
      • 11.3.2.1. Overview
      • 11.3.2.2. Segments and Application
      • 11.3.2.3. Key Financials
      • 11.3.2.4. Market Developments
      • 11.3.2.5. Market Strategy
    • 11.3.3. Baxter Healthcare
      • 11.3.3.1. Overview
      • 11.3.3.2. Segments and Application
      • 11.3.3.3. Key Financials
      • 11.3.3.4. Market Developments
      • 11.3.3.5. Market Strategy
    • 11.3.4. ICU Medical Inc.
      • 11.3.4.1. Overview
      • 11.3.4.2. Segments and Application
      • 11.3.4.3. Key Financials
      • 11.3.4.4. Market Developments
      • 11.3.4.5. Market Strategy
    • 11.3.5. Hospira
      • 11.3.5.1. Overview
      • 11.3.5.2. Segments and Application
      • 11.3.5.3. Key Financials
      • 11.3.5.4. Market Developments
      • 11.3.5.5. Market Strategy
    • 11.3.6. Q.I. Medical Inc.
      • 11.3.6.1. Overview
      • 11.3.6.2. Segments and Application
      • 11.3.6.3. Key Financials
      • 11.3.6.4. Market Developments
      • 11.3.6.5. Market Strategy
    • 11.3.7. Pfizer
      • 11.3.7.1. Overview
      • 11.3.7.2. Segments and Application
      • 11.3.7.3. Key Financials
      • 11.3.7.4. Market Developments
      • 11.3.7.5. Market Strategy
    • 11.3.8. Unilife Corporation
      • 11.3.8.1. Overview
      • 11.3.8.2. Segments and Application
      • 11.3.8.3. Key Financials
      • 11.3.8.4. Market Developments
      • 11.3.8.5. Market Strategy
    • 11.3.9. Amedra Pharmaceuticals
      • 11.3.9.1. Overview
      • 11.3.9.2. Segments and Application
      • 11.3.9.3. Key Financials
      • 11.3.9.4. Market Developments
      • 11.3.9.5. Market Strategy
    • 11.3.10. Sanofi
      • 11.3.10.1. Overview
      • 11.3.10.2. Segments and Application
      • 11.3.10.3. Key Financials
      • 11.3.10.4. Market Developments
      • 11.3.10.5. Market Strategy
    • 11.3.11. Biogen Idec
      • 11.3.11.1. Overview
      • 11.3.11.2. Segments and Application
      • 11.3.11.3. Key Financials
      • 11.3.11.4. Market Developments
      • 11.3.11.5. Market Strategy
    • 11.3.12. BIONIK Laboratories Corp.
      • 11.3.12.1. Overview
      • 11.3.12.2. Segments and Application
      • 11.3.12.3. Key Financials
      • 11.3.12.4. Market Developments
      • 11.3.12.5. Market Strategy
    • 11.3.13. Ekso Bionics Holdings Inc.
      • 11.3.13.1. Overview
      • 11.3.13.2. Segments and Application
      • 11.3.13.3. Key Financials
      • 11.3.13.4. Market Developments
      • 11.3.13.5. Market Strategy

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations